stockrowAchieve Life Sciences, Inc. (ACHV) vs Zevra Therapeutics, Inc. (ZVRA)
- Achieve Life Sciences, Inc. ACHV 6.73 +5.49%
- Zevra Therapeutics, Inc. ZVRA 11.55 +9.69%
Achieve Life Sciences, Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Achieve Life Sciences, Inc. and Zevra Therapeutics, Inc. are of similar size ($656.0M and $626.6M). Achieve Life Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 9.0×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 75.1% against −5.58%. Zevra Therapeutics, Inc. has the higher net margin (50.7% vs 0.00%) and the higher return on invested capital (129.5% vs 0.00%). Across the 17 metrics below, Zevra Therapeutics, Inc. leads on 15 and Achieve Life Sciences, Inc. on 2.
Valuation
Profitability
| Metric | ACHV | ZVRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.44% | 68.51% |
| Operating margin | 0.00% | 60.78% | 0.00% |
| Net margin | 0.00% | 50.73% | 0.00% |
| Free cash flow margin | 0.00% | 58.93% | 0.00% |
| Return on equity | (844.99%) | 40.29% | (51.96%) |
| Return on assets | (91.46%) | 25.69% | (46.06%) |
| Return on invested capital | 0.00% | 129.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack